Most Research Projects Stall at the Analysis Stage
Sequencing is cheaper than ever. The real bottleneck is what happens after the data arrives.
Wet-lab teams generate gigabytes of genomic data and then wait — weeks, sometimes months — for someone with the right computational skills to begin. PhD students spend a year learning pipelines instead of doing science. Lab budgets disappear on software licenses and cloud compute. And when an analysis finally runs, there is no guarantee it was set up correctly for the biology at hand.
BioinformaticsNext exists to close that gap — turning raw sequencing data into defensible, peer-reviewer-ready results without pulling your team off the bench.
What researchers tell us before working with us
"Our bioinformatician left mid-project and no one else in the lab could continue the analysis."
"A reviewer asked us to redo the differential expression with a different normalisation method. We had no idea how."
"We ran the pipeline ourselves but the figures were not to journal standards and we kept getting minor revision after minor revision."
"Our institute doesn't have a dedicated bioinformatics core — every project starts from scratch."
We Think Like Co-Authors, Not Service Providers
Our job is not simply to run software. It is to understand your biology and make sure the computational decisions reflect it accurately.
Biology-first design
Before we touch a FASTQ file we ask: What is the biological question? What confounders exist in this cohort? What does this journal's reviewer community expect in the methods? The pipeline is shaped by those answers — not the other way around.
Statistical rigour at every step
We do not apply a statistical test because it is the default. We select models based on your sample size, experimental design, and data distribution — and we document every assumption so reviewers cannot challenge the rationale.
Interpretation, not just output
Results without biological context are data, not findings. We include pathway-level interpretation, cross-reference with current literature, and flag results that warrant experimental validation — so you know what the numbers mean, not just what they are.
Methods written for peer review
Every project includes a draft methods section written to the specific style and technical depth expected by your target journal — including software versions, parameter choices, reference databases, and statistical thresholds.
The Seven Most Common Bioinformatics Mistakes — and How We Prevent Them
These are the issues that lead to major revision requests, retracted analyses, and delayed publications.
Skipping or under-reporting QC
Low-quality reads, adapter contamination, and lane-level batch effects invalidate downstream results if not caught and documented before analysis. We run MultiQC reports and flag every sample that sits outside acceptable thresholds before a single alignment begins.
Wrong normalisation for the data type
Using RPKM on count data, or TPM where library size correction is critical, introduces systematic bias. We select normalisation strategies specific to your sequencing depth, experimental design, and downstream application — and justify the choice in the methods.
Ignoring batch effects
Samples processed on different days, by different operators, or on different flow-cell runs carry technical variation that masquerades as biology. We identify and correct for batch effects using ComBat, limma's removeBatchEffect, or mixed model approaches as appropriate.
Multiple testing without correction
Reporting raw p-values across thousands of genomic features inflates false discovery rates to unacceptable levels. We apply Benjamini-Hochberg FDR or Bonferroni correction as appropriate, and explain the choice in a way reviewers cannot challenge.
Using outdated reference genomes
Aligning to GRCh37 when the journal and comparison datasets use GRCh38 creates coordinate mismatches and inconsistencies that reviewers catch immediately. We confirm reference assembly versions match your field's current standard before any alignment runs.
Over-clustering in single-cell data
Choosing resolution parameters that produce too many clusters leads to biologically meaningless cell populations that collapse under scrutiny. We tune resolution against known marker genes and validate cluster identity before annotating any cell type.
Publication-quality figures as an afterthought
Screenshots of RStudio plots, mismatched colour schemes, and unlabelled axes are among the most common minor revision triggers. Every figure we deliver is formatted to journal resolution standards (300 dpi minimum), with consistent colour palettes and accessible design choices.
BioinformaticsNext vs. Your Alternatives
Honestly assessing every option available to a research team today.
| Consideration | BioinformaticsNext | Hiring in-house | Generic freelancer | Doing it yourself |
|---|---|---|---|---|
| Time to first result | 3–14 days | 3–6 months to hire | Variable, often weeks | Months of learning |
| Breadth of expertise | Multi-omics, AI, structural, clinical | One or two specialisms | Narrow and unverified | Limited to self-taught tools |
| Peer-review support | Included, unlimited revisions | Depends on contract | Rarely included | Self-managed |
| Cost model | Per-project, no overhead | Salary + benefits + licences | Hourly, unpredictable | Staff time + compute costs |
| Continuity if key person leaves | Team-based, always continuous | Project stalls | Project stalls | Depends on documentation |
| Reproducible, documented pipelines | Standard on every project | Varies by individual | Rarely provided | Requires significant effort |
| NDA and data security | Standard, signed before data transfer | Employment contract only | Not always available | Internal only |
⏱ Time to first result
✔ BioinformaticsNext: 3–14 days
In-house hire: 3–6 months · Freelancer: Variable · DIY: Months of learning
🔬 Breadth of expertise
✔ BioinformaticsNext: Multi-omics, AI, structural, clinical
In-house: One or two specialisms · Freelancer: Narrow and unverified · DIY: Self-taught tools only
📝 Peer-review support
✔ BioinformaticsNext: Included, unlimited revision rounds
In-house: Depends on contract · Freelancer: Rarely included · DIY: Self-managed
💰 Cost model
✔ BioinformaticsNext: Per-project, no overhead
In-house: Salary + benefits + licences · Freelancer: Hourly, unpredictable · DIY: Staff time + compute
🔄 Continuity if key person leaves
✔ BioinformaticsNext: Team-based, always continuous
In-house: Project stalls · Freelancer: Project stalls · DIY: Depends on your documentation
📂 Reproducible, documented pipelines
✔ BioinformaticsNext: Standard on every project
In-house: Varies by individual · Freelancer: Rarely provided · DIY: Requires significant extra effort
🔒 NDA and data security
✔ BioinformaticsNext: Signed before any data is shared
In-house: Employment contract only · Freelancer: Not always available · DIY: Internal only
We Also Take Over Analyses That Have Stalled or Failed
Not every project starts from scratch. We regularly step into situations where an existing analysis has produced results a reviewer has challenged, where a previous analyst has left the project incomplete, or where an in-house pipeline has produced outputs that do not make biological sense.
We begin with an independent audit of what has been done, identify where the analysis diverged from best practice, and rebuild only the parts that need correction — preserving your timeline and avoiding duplication of work already done well.
Reviewer response
Reanalysis aligned to specific reviewer comments
Pipeline takeover
Continuation of work left incomplete by a previous analyst
Results audit
Independent check of an analysis before submission
Common rescue requests we handle
"Reviewer 2 asked for a new DEG analysis using a different reference genome assembly."
"Our bioinformatician left the university and nobody can reproduce the figures in the submitted manuscript."
"The clustering in our scRNA-seq paper was challenged as over-resolved. We need to re-annotate and resubmit within 30 days."
"We ran the pipeline ourselves but the volcano plots are not publication quality and keep getting flagged."
What Our Quality Assurance Process Actually Looks Like
Every project passes through four checkpoints before results leave our team. This is what prevents the errors described above from ever reaching your manuscript.
Pre-analysis data audit
Before any pipeline runs, we audit raw data quality, check for format integrity, confirm sample identities match the metadata sheet, and document the starting state of the dataset. Anomalies are flagged and discussed with you before work proceeds — not discovered after.
Interim review checkpoint
Midway through the analysis we share preliminary outputs — alignment statistics, QC metrics, exploratory plots — so you can confirm the direction before the full pipeline completes. Changes at this stage cost far less time than changes at delivery.
Internal peer review
A second bioinformatician independent of the project reviews all code, parameter choices, and output interpretations before we finalise results. This mirrors the peer-review process your manuscript will face — catching issues before they reach a journal referee.
Reproducibility package
Every deliverable includes commented, versioned analysis scripts, a software environment file (conda/renv), and a step-by-step README. You can reproduce every figure in the paper from scratch — and so can a reviewer who requests data availability compliance.
Who Works With Us
We adapt to the working style and constraints of each research context.
PhD Researchers
Thesis chapters often contain a computational analysis chapter that is entirely outside a student's training. We complete that chapter, properly documented, so the student understands what was done and can defend it in their viva.
Thesis support Explainable resultsAcademic Research Groups
Labs that sequence regularly but lack a dedicated computational core use us as an on-demand bioinformatics resource — scaling up for large grant deliverables and scaling back during quieter periods.
Flexible capacity Grant-aligned timelinesBiotech & Pharma Teams
Early-stage companies need publication-grade analysis to support IP filings, investor decks, and regulatory submissions — without the cost of building an in-house bioinformatics function from scratch.
IP-supportive documentation Regulatory-ready reportsClinical & Hospital Research Units
Clinical teams running genomics studies on patient cohorts need results that will survive regulatory and ethical scrutiny. We provide the rigour, documentation, and data handling standards that clinical research demands.
Patient data protocols Ethics-compatible workflowsData Security Beyond the NDA
An NDA is the minimum. Here is what we actually do to protect your unpublished research.
Isolated project environments
Each project runs in a dedicated, access-controlled compute environment. No data from one client project is ever co-located with another.
Encrypted transfer only
All data is transferred over encrypted channels. We do not accept data via unencrypted email attachments or unprotected shared drives.
Data deletion on completion
Raw data is securely deleted from our servers within 30 days of project completion unless you explicitly request extended retention for follow-up work.
What to Expect From Day One
Our collaboration model is designed around researchers who are busy, often under deadline pressure, and need communication that does not create more work than it solves.
- → Single point of contact. You work with one named project lead throughout — no ticket systems, no rotating support queues.
- → Agreed scope in writing. Before work begins you receive a written project brief confirming the analysis plan, timeline, and deliverables — no ambiguity about what is included.
- → Progress updates, not silence. We provide scheduled updates at agreed milestones — you are never left wondering where your project stands.
- → Plain-language summaries. Every set of results comes with a plain-English summary written for a wet-lab scientist, alongside the full technical report.
Frequently asked at first contact
Can you work with data we have already partially analysed?
Yes. We can audit existing work, identify where it needs correction, and continue from any stage of an analysis rather than starting over unnecessarily.
We do not know which analysis our data needs. Can you advise?
This is one of the most common starting points. Send us your research question and your data type and we will recommend an analysis plan before any commitment is required.
We are under a tight submission deadline. Is that workable?
Provide your deadline in your first message. We will confirm within 24 hours whether we can meet it or propose the fastest realistic alternative.
Will we be able to explain the methods in our viva or to reviewers?
Every deliverable includes a plain-language methods narrative alongside the technical documentation. We also offer a 30-minute walkthrough call so you understand every decision made in your analysis.
What Researchers Say About Working With Us
From PhD students defending their thesis to clinical teams submitting to high-impact journals — in their own words.
"I had six months of scRNA-seq data and no idea how to analyse it. BioinformaticsNext built the entire Seurat pipeline, annotated all cell clusters against published markers, and delivered figures that went straight into my thesis. My supervisor said it was the strongest chapter in the whole document."
Dr. S. P****l
PhD Graduate, Oncology & Cancer Biology — University of Manchester
"We submitted to Nature Communications and reviewer three asked for a complete reanalysis using a different normalisation method and an additional batch correction step. BioinformaticsNext turned it around in five days. The revised figures were stronger than our originals and the paper was accepted at the next round."
Prof. M. R****d
Principal Investigator, Immunogenomics Lab — King's College London
"As a biotech startup we needed publication-grade genomics analysis to support our Series A raise, but could not justify a full-time hire. The team at BioinformaticsNext delivered a multi-omics target identification report with NDA in place, on time and within budget. Our scientific advisors were impressed with the depth."
Dr. L. K****s
Chief Scientific Officer — PrecisionOmics Therapeutics, Budapest
"Our postdoc left halfway through a metagenomics project and took all the analysis knowledge with them. BioinformaticsNext audited what existed, told us clearly what was salvageable, and completed the pipeline in three weeks. They even wrote the methods section for our submission to Microbiome journal."
Dr. C. O*****r
Associate Professor, Microbiology & Infectious Disease — University of Lagos
"I contacted BioinformaticsNext two weeks before my viva, worried I could not explain the GWAS pipeline in my thesis. They did a 30-minute walkthrough of every analytical decision — the statistical model, the population stratification correction, the significance thresholds. I walked into my viva confident and passed without corrections."
R. F*******z
PhD Candidate, Human Genetics & Population Genomics — University of Barcelona
"We run a clinical genomics programme across three hospital sites and needed a bioinformatics partner who understood both the science and the data governance requirements. BioinformaticsNext signed our institutional data agreement, processed our WES cohort with full audit trail documentation, and delivered a variant interpretation report our clinical team could actually use."
Dr. A. N*****n
Clinical Research Lead, Genomic Medicine Unit — Singapore General Hospital
Start With a Free Consultation
Describe your data, your research question, and your deadline. We will come back with an honest assessment of what the analysis involves, how long it will take, and what it will cost — before you commit to anything.
No commitment required · Response within 24 hours · NDA signed before any data is shared
